| dc.contributor.author | O'Byrne, Ken | en |
| dc.date.accessioned | 2018-10-09T10:38:52Z | |
| dc.date.available | 2018-10-09T10:38:52Z | |
| dc.date.issued | 2018 | en |
| dc.date.submitted | 2018 | en |
| dc.identifier.citation | Suraweera, A. and O'Byrne, K.J. and Richard, D.J., Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi, Frontiers in Oncology, 8, MAR, 2018, 92- | en |
| dc.identifier.other | Y | en |
| dc.description | PUBLISHED | en |
| dc.description | cited By 2 | en |
| dc.format.extent | 92 | en |
| dc.relation.ispartofseries | Frontiers in Oncology | en |
| dc.relation.ispartofseries | 8 | en |
| dc.relation.ispartofseries | MAR | en |
| dc.rights | Y | en |
| dc.title | Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: Achieving the full therapeutic potential of HDACi | en |
| dc.type | Journal Article | en |
| dc.type.supercollection | scholarly_publications | en |
| dc.type.supercollection | refereed_publications | en |
| dc.identifier.peoplefinderurl | http://people.tcd.ie/obyrneke | en |
| dc.identifier.rssinternalid | 192355 | en |
| dc.identifier.doi | http://dx.doi.org/10.3389/fonc.2018.00092 | en |
| dc.rights.ecaccessrights | openAccess | |
| dc.identifier.uri | http://hdl.handle.net/2262/85083 | |
